TIG3 activators refer to a group of chemical agents that aim to upregulate or enhance the activity of TIG3, also known as Tazarotene-induced gene 3. TIG3 is a member of the retinoic acid-inducible gene family and is known to be involved in cellular processes such as the regulation of cell proliferation, differentiation, and apoptosis. The protein encoded by this gene is believed to play a role in maintaining cellular homeostasis and has been observed to be expressed in a variety of tissue types. TIG3 activators would, therefore, interact with this protein in a way that increases its biological activity or expression, which could have numerous downstream effects on cellular functions. These activators may exert their effects by binding directly to TIG3 or by influencing the pathways that regulate the expression levels or stability of TIG3 protein within the cell.
The discovery and development of TIG3 activators is a complex process that requires a deep understanding of the protein's structure and function. This knowledge is crucial to identify potential binding sites or regulatory regions on the TIG3 protein that could be targeted by small molecules or other types of chemical agents. Structural studies, such as X-ray crystallography or NMR spectroscopy, provide detailed insights into the three-dimensional conformation of TIG3 and facilitate the rational design of activators that can interact with the protein in a specific and efficient manner. Moreover, advanced computational methods, including molecular docking and virtual screening, are often employed to predict how potential activators might interact with TIG3 and to guide the synthesis of compounds with increased potency and selectivity. Through iterative cycles of design, synthesis, and biological evaluation, researchers can optimize TIG3 activators to exhibit the desired effect on the protein's activity.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Tazarotene | 118292-40-3 | sc-220193 | 10 mg | $103.00 | ||
Tazarotene, a synthetic retinoid, has been shown to directly upregulate the expression of TIG3, possibly through its high binding affinity to retinoid receptors, which triggers transcriptional changes. | ||||||
13-cis-Retinoic acid | 4759-48-2 | sc-205568 sc-205568A | 100 mg 250 mg | $74.00 $118.00 | 8 | |
13-cis-Retinoic acid, a retinoid used in dermatology, could hypothetically stimulate the expression of TIG3 by binding to retinoid receptors and activating signal transduction pathways. | ||||||
Acitretin | 55079-83-9 | sc-210754 | 25 mg | $148.00 | 1 | |
Acitretin, a second-generation retinoid, has the potential to induce TIG3 expression as a result of its ability to bind to retinoid receptors, thus triggering a series of transcriptional changes. | ||||||
Adapalene | 106685-40-9 | sc-203803 sc-203803A | 10 mg 50 mg | $65.00 $325.00 | 2 | |
Adapalene is a third-generation retinoid that selectively binds to nuclear retinoic acid receptors, which could hypothetically lead to an increase in TIG3 expression. | ||||||
Bexarotene | 153559-49-0 | sc-217753 sc-217753A | 10 mg 100 mg | $54.00 $245.00 | 6 | |
Bexarotene, a retinoid selective for retinoid X receptors (RXRs), could potentially stimulate the TIG3 gene by activating these receptors, initiating a downstream increase in TIG3 protein production. | ||||||
9-cis-Retinoic acid | 5300-03-8 | sc-205589 sc-205589B sc-205589C sc-205589D sc-205589A | 1 mg 25 mg 250 mg 500 mg 5 mg | $70.00 $416.00 $3060.00 $5610.00 $145.00 | 10 | |
9-cis-Retinoic acid, a naturally occurring derivative of Vitamin A, could hypothetically bind to retinoid receptors, initiating a cascade of events that leads to the upregulation of TIG3 expression. | ||||||
4-Hydroxyphenylretinamide | 65646-68-6 | sc-200900 sc-200900A | 5 mg 25 mg | $104.00 $315.00 | ||
4-Hydroxyphenylretinamide, a synthetic retinoid, has the potential to stimulate the expression of the TIG3 gene through its interaction with retinoid receptors, setting off a series of events that increase TIG3 protein production. | ||||||
TTNPB | 71441-28-6 | sc-203303 sc-203303A sc-203303B | 10 mg 25 mg 50 mg | $206.00 $340.00 $562.00 | 20 | |
TTNPB, a synthetic retinoid, could potentially stimulate the TIG3 gene and increase its expression by interacting with retinoid receptors. | ||||||